Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Isabel Tritschler"'
Autor:
Tobias Fretwurst, Isabel Tritschler, René Rothweiler, Susanne Nahles, Brigitte Altmann, Oliver Schilling, Katja Nelson
Publikováno v:
Proteomics. Clinical applicationsREFERENCES. 16(5)
The study aim is a comparative proteome-based analysis of different autologous bone entities (alveolar bone [AB], iliac cortical [IC] bone, and iliac spongiosa [IS]) used for alveolar onlay grafting.Site-matched bone samples of AB, IC, and IS were ha
Autor:
Antonella Palla, Christoph Renner, Ghazaleh Tabatabai, Isabel Tritschler, Michael Weller, Hans-Georg Wirsching
Publikováno v:
Neuro-Oncology Practice. 1:178-183
Lomustine is an oral alkylating drug commonly used for brain tumor patients. Recently, the lomustine-containing PCV polychemotherapy regime (procarbazine, CCNU/lomustine, and vincristine) in combination with radiotherapy has become the standard of ca
Autor:
Peter Schraml, Isabel Tritschler, Simon L. Goodman, Ghazaleh Tabatabai, Michaela Weller, Gabriele Maurer, Manuela Silginer, Patrick Roth, Kathy Hasenbach, Svenja Thies, Holger Moch
Transforming growth factor-β is a central mediator of the malignant phenotype of glioblastoma, the most common and malignant form of intrinsic brain tumours. Transforming growth factor-β promotes invasiveness and angiogenesis, maintains cancer cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f319f56903962af11f98560b47653f10
http://doc.rero.ch/record/304868/files/aws351.pdf
http://doc.rero.ch/record/304868/files/aws351.pdf
Publikováno v:
Neuro-Oncology. 16:382-391
BackgroundThere are emerging reports that the family of a disintegrin and metalloproteinases (ADAM) are involved in the maintenance of the malignant phenotype of glioblastomas. Notably, ADAM proteases 10 and 17 might impair the immune recognition of
Autor:
Saskia Trump, Christiane A. Opitz, Bernhard Radlwimmer, Andreas von Deimling, Michael Weller, Wolfgang Wick, Theresa Schumacher, Christine L. Miller, Dieter Schrenk, Leonie Jestaedt, Irina Lehmann, Manfred Jugold, Gilles J. Guillemin, Martina Ott, Isabel Tritschler, Felix Sahm, Michael Platten, Christian Lutz, Ulrike M. Litzenburger
Publikováno v:
Nature. 478:197-203
Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals, for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety of cellular processes such as embryogenesis, transformation, tu
Autor:
Samuel N. Breit, Patrick Roth, Wolfgang Wick, Yvonne Dombrowski, Markus Junker, Isabel Tritschler, Jörg Wischhusen, Ghazaleh Tabatabai, Michael Weller, Michel Mittelbronn
Publikováno v:
Clinical Cancer Research. 16:3851-3859
Purpose: Growth and differentiation factor (GDF)-15 is a member of the transforming growth factor (TGF)-β family. GDF-15 is necessary for the maintenance of pregnancy but has also been linked to other physiologic and pathologic conditions. Experimen
Autor:
Wolfgang Wick, Jorma Keski-Oja, Michel Mittelbronn, Isabel Tritschler, Juha Saharinen, David Capper, Richard Meyermann, Michael Weller, Dorothee Gramatzki
Publikováno v:
International Journal of Cancer. 125:530-540
High biological activity of the transforming growth factor (TGF)-beta-Smad pathway characterizes the malignant phenotype of malignant gliomas and confers poor prognosis to glioma patients. Accordingly, TGF-beta has become a novel target for the exper
Autor:
G Pantazis, D Gramatzki, Isabel Tritschler, Wolfgang Wick, Ghazaleh Tabatabai, Jens Schittenhelm, Michael Schwarz, C Köhle, M. Weller
Publikováno v:
Oncogene. 28:2593-2605
The dioxin/aryl hydrocarbon receptor (AhR) is a transcription factor, which has been attributed a role in human cancerogenesis, cell cycle progression and transforming growth factor-beta (TGF-beta) signaling. As TGF-beta is an important mediator of t
Autor:
Wilhelm K. Aicher, Alexandra Köppel, Eva Tolosa, Jan Anderl, Wolfgang Wick, Christiane A. Opitz, Isabel Tritschler, Michael Weller, Michael Platten, Christian Lutz, Ulrike M. Litzenburger, Maik Hoberg, Tobias V. Lanz
Publikováno v:
Stem Cells. 27:909-919
Mesenchymal stem cells (MSC) display unique suppressive properties on T-cell immunity, thus representing an attractive vehicle for the treatment of conditions associated with harmful T-cell responses such as organ-specific autoimmunity and graft-vers
Background. The transforming growth factor (TGF)-b and vascular endothelial growth factor (VEGF) pathways have a major role in the pathogenesis of glioblastoma, notably immunosuppression, migration, and angiogenesis, but their interactions have remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7e9e6aca4d4b54c0231b47710a79e9
https://www.zora.uzh.ch/id/eprint/98683/
https://www.zora.uzh.ch/id/eprint/98683/